The projected standardized rates of leukemia mortality in Japan for women are expected to slightly decline from 2024 to 2028. These rates maintain stability at 2.9 female deaths per hundred thousand women from 2024 to 2026 and decrease to 2.8 from 2027 onwards. In comparison to 2023, when the rate stood at 3.0, the year-on-year change reflects a reduction of approximately 3.3% by 2027. Though marginal, this downward trend across five years results in a compound annual growth rate (CAGR) of approximately -1.4% in female leukemia mortality rates.
Future trends to watch for include potential advances in medical research and treatments, public health campaigns improving early detection and prevention, and demographic changes impacting overall health metrics. Technological innovations in healthcare and regulatory changes could significantly influence these rates. Monitoring these factors may provide actionable insights to address and further reduce leukemia mortality rates in Japan.
